{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:33:44Z","timestamp":1774384424649,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science and Technology project of Henan Province","award":["LHGJ20230460"],"award-info":[{"award-number":["LHGJ20230460"]}]},{"name":"Medical Science and Technology project of Henan Province","award":["LHGJ20200582"],"award-info":[{"award-number":["LHGJ20200582"]}]},{"name":"Scientific Research Foundation of Anhui Medical University","award":["2023xkj037"],"award-info":[{"award-number":["2023xkj037"]}]},{"name":"The Key Natural Science Research Projects of Universities in Anhui Province","award":["2024AH050805"],"award-info":[{"award-number":["2024AH050805"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06109-0","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:52:10Z","timestamp":1773258730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2760-8580","authenticated-orcid":false,"given":"Shiyong","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianchao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingshuai","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangli","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"6","key":"6109_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"6109_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F et al (2021) Epidemiology and prevention of prostate cancer. Eur Urol Oncol 4(6):877\u2013892","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"6109_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K et al (2023) 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol 84(2):191\u2013206","journal-title":"Eur Urol"},{"key":"6109_CR4","doi-asserted-by":"crossref","unstructured":"Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.","DOI":"10.1136\/bmj.k3519"},{"issue":"1","key":"6109_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.juro.2006.08.057","volume":"177","author":"CJ Kane","year":"2007","unstructured":"Kane CJ, Presti JC Jr, Amling CL et al (2007) Changing nature of high risk patients undergoing radical prostatectomy. J Urol 177(1):113\u2013117","journal-title":"J Urol"},{"issue":"4","key":"6109_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.eururo.2020.01.012","volume":"77","author":"S Gillessen","year":"2020","unstructured":"Gillessen S, Attard G, Beer TM et al (2020) Management of patients with advanced prostate cancer: report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol 77(4):508\u2013547","journal-title":"Eur Urol"},{"issue":"1","key":"6109_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eururo.2018.03.028","volume":"75","author":"P Nuhn","year":"2019","unstructured":"Nuhn P, De Bono JS, Fizazi K et al (2019) Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur Urol 75(1):88\u201399","journal-title":"Eur Urol"},{"issue":"13","key":"6109_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1200\/JCO.18.02031","volume":"37","author":"JL Gulley","year":"2019","unstructured":"Gulley JL, Borre M, Vogelzang NJ et al (2019) Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. J Clin Oncol 37(13):1051\u20131061","journal-title":"J Clin Oncol"},{"issue":"6","key":"6109_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1165377","volume":"5","author":"BT Rekoske","year":"2016","unstructured":"Rekoske BT, Olson BM, McNeel DG (2016) Antitumor vaccination of prostate cancer patients elicits PD-1\/PD-L1 regulated antigen-specific immune responses. Oncoimmunology 5(6):e1165377","journal-title":"Oncoimmunology"},{"issue":"8","key":"6109_CR10","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1158\/1078-0432.CCR-15-2042","volume":"22","author":"H Gevensleben","year":"2016","unstructured":"Gevensleben H, Dietrich D, Golletz C et al (2016) The immune checkpoint regulator PD-L1 is highly expressed in aggressive primary prostate cancer. Clin Cancer Res 22(8):1969\u20131977","journal-title":"Clin Cancer Res"},{"issue":"6","key":"6109_CR11","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.ymthe.2021.04.029","volume":"29","author":"Y Xu","year":"2021","unstructured":"Xu Y, Song G, Xie S et al (2021) The roles of PD-1\/PD-L1 in the prognosis and immunotherapy of prostate cancer. Mol Ther 29(6):1958\u20131969","journal-title":"Mol Ther"},{"issue":"4","key":"6109_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3223","volume":"12","author":"SS Kwek","year":"2012","unstructured":"Kwek SS, Cha E, Fong L (2012) Unmasking the immune recognition of prostate cancer with CTLA4 blockade. Nat Rev Cancer 12(4):289\u2013297","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"6109_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112810","volume":"20","author":"WX Huff","year":"2019","unstructured":"Huff WX, Kwon JH, Henriquez M, Fetcko K, Dey M (2019) The evolving role of CD8\u2009+\u2009CD28- immunosenescent T cells in cancer immunology. Int J Mol Sci 20(11):2810","journal-title":"Int J Mol Sci"},{"key":"6109_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451\u2013483","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"6109_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196(3):254\u2013265","journal-title":"J Pathol"},{"issue":"1","key":"6109_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00407-0","volume":"12","author":"S Xin","year":"2023","unstructured":"Xin S, Liu X, Li Z et al (2023) ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer. Exp Hematol Oncol 12(1):49","journal-title":"Exp Hematol Oncol"},{"issue":"6282","key":"6109_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y et al (2016) MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352(6282):227\u2013231","journal-title":"Science"},{"issue":"5","key":"6109_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A (2015) Spatial reconstruction of single-cell gene expression data. Nat Biotechnol 33(5):495\u2013502","journal-title":"Nat Biotechnol"},{"issue":"5","key":"6109_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R et al (2015) Highly parallel Genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161(5):1202\u20131214","journal-title":"Cell"},{"issue":"1","key":"6109_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51450-2","volume":"15","author":"MK Graham","year":"2024","unstructured":"Graham MK, Wang R, Chikarmane R et al (2024) Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Nat Commun 15(1):7414","journal-title":"Nat Commun"},{"issue":"1","key":"6109_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A et al (2022) Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer 21(1):132","journal-title":"Mol Cancer"},{"issue":"2","key":"6109_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20(2):163\u2013172","journal-title":"Nat Immunol"},{"issue":"4","key":"6109_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J et al (2014) The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 32(4):381\u2013386","journal-title":"Nat Biotechnol"},{"issue":"7","key":"6109_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47","journal-title":"Nucleic Acids Res"},{"key":"6109_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"key":"6109_CR26","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2147\/OTT.S160493","volume":"11","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Dong W (2018) Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma. Onco Targets Ther 11:1563\u20131570","journal-title":"Onco Targets Ther"},{"key":"6109_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106378","volume":"83","author":"DJ Lee","year":"2020","unstructured":"Lee DJ (2020) The relationship between TIGIT+ regulatory T cells and autoimmune disease. Int Immunopharmacol 83:106378","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"6109_CR28","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.7150\/thno.40860","volume":"10","author":"T Hu","year":"2020","unstructured":"Hu T, Liu H, Liang Z et al (2020) Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis. Theranostics 10(9):4056\u20134072","journal-title":"Theranostics"},{"issue":"10","key":"6109_CR29","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1158\/0008-5472.CAN-23-2986","volume":"84","author":"M Song","year":"2024","unstructured":"Song M, Zhang C, Cheng S et al (2024) DNA of neutrophil extracellular traps binds TMCO6 to impair CD8\u2009+\u2009T-cell immunity in hepatocellular carcinoma. Cancer Res 84(10):1613\u20131629","journal-title":"Cancer Res"},{"issue":"9","key":"6109_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005433","volume":"10","author":"A Li","year":"2022","unstructured":"Li A, Chang Y, Song NJ et al (2022) Selective targeting of GARP-LTGF\u03b2 axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8\u2009+\u2009T cell antitumor immunity. J Immunother Cancer 10(9):e005433","journal-title":"J Immunother Cancer"},{"issue":"5","key":"6109_CR31","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.7150\/thno.103175","volume":"15","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhang C, Xiao J et al (2025) TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance. Theranostics 15(5):1966\u20131986","journal-title":"Theranostics"},{"issue":"3","key":"6109_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.trecan.2020.01.003","volume":"6","author":"LT Nicholson","year":"2020","unstructured":"Nicholson LT, Fong L (2020) Immune checkpoint inhibition in prostate cancer. Trends Cancer 6(3):174\u2013177","journal-title":"Trends Cancer"},{"key":"6109_CR33","doi-asserted-by":"crossref","unstructured":"Prostate cancer. Nat Rev Dis Primers. 2021;7(1):8. Published 2021 Feb 4.","DOI":"10.1038\/s41572-021-00249-2"},{"issue":"1","key":"6109_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW (2022) The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol 19(1):23\u201336","journal-title":"Nat Rev Clin Oncol"},{"key":"6109_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102154","volume":"94","author":"MJ Duffy","year":"2021","unstructured":"Duffy MJ, O\u2019Grady S, Tang M, Crown J (2021) MYC as a target for cancer treatment. Cancer Treat Rev 94:102154","journal-title":"Cancer Treat Rev"},{"key":"6109_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686031","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yang Z, Yang Y (2021) Potential role of CD47-directed bispecific antibodies in cancer immunotherapy. Front Immunol 12:686031","journal-title":"Front Immunol"},{"issue":"5","key":"6109_CR37","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN (2020) The CD47-SIRP\u03b1 immune checkpoint. Immunity 52(5):742\u2013752","journal-title":"Immunity"},{"issue":"1","key":"6109_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/JOE-13-0341","volume":"220","author":"EK Choi","year":"2013","unstructured":"Choi EK, Kim WK, Sul OJ et al (2013) TNFRSF14 deficiency protects against ovariectomy-induced adipose tissue inflammation. J Endocrinol 220(1):25\u201333","journal-title":"J Endocrinol"},{"issue":"3","key":"6109_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN (2018) Regulation and function of the PD-L1 checkpoint. Immunity 48(3):434\u2013452","journal-title":"Immunity"},{"issue":"11","key":"6109_CR40","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W (2022) Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun (Lond) 42(11):1112\u20131140","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"6109_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36\u201350","journal-title":"Cell Metab"},{"issue":"10","key":"6109_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ (2002) Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol 2(10):735\u2013747","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6109_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03900-x","volume":"9","author":"JF Anker","year":"2018","unstructured":"Anker JF, Naseem AF, Mok H, Schaeffer AJ, Abdulkadir SA, Thumbikat P (2018) Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun 9(1):1591","journal-title":"Nat Commun"},{"issue":"1","key":"6109_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03195-5","volume":"43","author":"Z Yao","year":"2024","unstructured":"Yao Z, Zeng Y, Liu C et al (2024) Focusing on CD8\u2009+\u2009T-cell phenotypes: improving solid tumor therapy. J Exp Clin Cancer Res 43(1):266","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"6109_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957","volume":"8","author":"JM Chauvin","year":"2020","unstructured":"Chauvin JM, Zarour HM (2020) TIGIT in cancer immunotherapy. J Immunother Cancer 8(2):e000957","journal-title":"J Immunother Cancer"},{"issue":"11","key":"6109_CR46","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.immuni.2024.08.008","volume":"57","author":"D Kim","year":"2024","unstructured":"Kim D, Kim G, Yu R et al (2024) Inhibitory co-receptor Lag3 supports Foxp3\u2009+\u2009regulatory T cell function by restraining Myc-dependent metabolic programming. Immunity 57(11):2634-2650.e5","journal-title":"Immunity"},{"key":"6109_CR47","doi-asserted-by":"crossref","unstructured":"Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, et al. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer. 2011;129(2):355\u2013364.","DOI":"10.1002\/ijc.25704"},{"issue":"4","key":"6109_CR48","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.9736","volume":"21","author":"P Zhong","year":"2021","unstructured":"Zhong P, Shu R, Wu H, Liu Z, Shen X, Hu Y (2021) Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma. Exp Ther Med 21(4):305","journal-title":"Exp Ther Med"},{"issue":"1","key":"6109_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/CS20050115","volume":"110","author":"SE Williams","year":"2006","unstructured":"Williams SE, Brown TI, Roghanian A, Sallenave JM (2006) SLPI and elafin: one glove, many fingers. Clin Sci Lond 110(1):21\u201335","journal-title":"Clin Sci Lond"},{"issue":"6","key":"6109_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00262-011-1018-2","volume":"60","author":"N Amiano","year":"2011","unstructured":"Amiano N, Reiteri RM, Costa MJ, Tateosian N, Chuluyan HE (2011) Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth. Cancer Immunol Immunother 60(6):895\u2013900","journal-title":"Cancer Immunol Immunother"},{"key":"6109_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/507315","volume":"2015","author":"N McGarry","year":"2015","unstructured":"McGarry N, Greene CM, McElvaney NG, Weldon S, Taggart CC (2015) The ability of secretory leukocyte protease inhibitor to inhibit apoptosis in monocytes is independent of its antiprotease activity. J Immunol Res 2015:507315","journal-title":"J Immunol Res"},{"issue":"1","key":"6109_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7150\/ijbs.65676","volume":"18","author":"J Sun","year":"2022","unstructured":"Sun J, Li J, Wu Z et al (2022) SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis. Int J Biol Sci 18(1):140\u2013153","journal-title":"Int J Biol Sci"},{"key":"6109_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0486-y","volume":"15","author":"P Chandler","year":"2016","unstructured":"Chandler P, Kochupurakkal BS, Alam S, Richardson AL, Soybel DI, Kelleher SL (2016) Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer. Mol Cancer 15:2","journal-title":"Mol Cancer"},{"issue":"3","key":"6109_CR54","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13197","volume":"23","author":"Z Wan","year":"2022","unstructured":"Wan Z, Wang X (2022) Role of SLC39A6 in the development and progression of liver cancer. Oncol Lett 23(3):77","journal-title":"Oncol Lett"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06109-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:02:31Z","timestamp":1774371751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6109"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06109-0","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki. De-identified linked records were obtained from the TCGA database in accordance with the database policy. Institutional review board approval and informed consent were not required for the analysis of de-identified data from the TCGA database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}